A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ever before. Researchers identified two previously unknown proteins in the ...

March 18 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." According to the NIH, Alzheimer's disease accounts for up to two-thirds of dementia cases in people 65 ...

An integrated suite of bioassays provides a coherent workflow to track antibody Fc effector activity across every stage of mAb drug development Potency assays that fail during tech transfer or ...

In a nutshell: As the global population ages, Alzheimer's disease has become one of the most common forms of dementia affecting older adults. Traditional diagnostic methods are often expensive and ...

New research shows a simple blood test can predict the onset of Alzheimer’s symptoms, leading to earlier therapeutic care Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...

A simple blood test could predict not only a person’s risk of developing Alzheimer’s disease, but also the year symptoms will begin. Researchers at the Washington University School of Medicine in St.

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Grail's Galleri test promises to detect cancer signals in your blood. It's good at finding advanced cancers, but can miss early-stage cases. Telehealth company Hims & Hers is offering Galleri at a ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. Quest Flow ...